Detection of a New blaOXA-51-Like Variant (blaOXA-1328) and a Novel Sequence Type (ST3457/2790) in Acinetobacter baumannii Isolated from Community Sewage and an Incinerator Surface in Nigeria
Listed in
This article is not in any list yet, why not save it to one of your lists.Abstract
Objective: Acinetobacter baumannii is an opportunistic pathogen with a high capacity to acquire antimicrobial resistance (AMR) determinants, including OXA-type β-lactamases, which confer carbapenem resistance. Environmental reservoirs play a crucial role in the persistence and spread of the bacteria, yet limited data exist on A. baumannii from non-hospital environments (which is critical in epidemiological studies) in Nigeria. This study aimed to study the genetic diversities of A. baumannii strains from different non-hospital environments in Nigeria, determine their sequence types (STs), and characterize their resistance genes. Results: While studying the prevalence of A. baumannii from 404 environmental samples (soil, sewage, water, and air) collected from three non-hospital communities in Nigeria, 2 isolates with novel features were discovered. Following culture-based and molecular identification, 33 isolates (7.5%) were confirmed as A. baumannii . Whole-genome sequencing (WGS) revealed the presence of one novel bla OXA-51 -like variant ( bla OXA1283 ) (that was diverged from bla OXA-180 variants that were previously isolated from different environments in Nigeria) and one sequence type (ST3457/2790). A variant (bla OXA-707 ) isolated from semi-pristine soil, is closely related to only one strain isolated from a stork bird in Poland. Another strain from an incinerator surface, clustered with strains from human oral sources in China, suggesting a potential link to clinical strains. The three isolates were susceptible to carbapenems (imipenem, meropenem), ceftazidime, tetracycline, gentamicin, sulfamethoxazole, and ciprofloxacin, suggesting minimal clinical exposure. However, a related strain carrying bla OXA-120 from Egypt has been reported with additional bla NDM-1 , a gene that mediates carbapenem resistance.